Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (501-510 of 519) with videos related to

Pageof 52
Sort By:
Genome Biology|March 28, 2008
A sequence-based survey of the complex structural organization of tumor genomesBenjamin J Raphael, Stanislav Volik, Peng Yu, et al.
Nature Medicine|April 3, 2023
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trialEugene Shenderov, Angelo M De Marzo, Tamara L Lotan, et al.
Neoplasia (New York, N.Y.)|October 26, 2012
Role of transcriptional corepressor CtBP1 in prostate cancer progressionRui Wang, Irfan A Asangani, Balabhadrapatruni V S K Chakravarthi, et al.
Human Molecular Genetics|May 13, 2004
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumorsPamela L Paris, Armann Andaya, Jane Fridlyand, et al.
Cancer Cell|May 18, 2011
Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancerJ Chad Brenner, Bushra Ateeq, Yong Li, et al.
JAMA Oncology|March 28, 2020
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical TrialRyan Phillips, William Yue Shi, Matthew Deek, et al.
Nature Genetics|October 1, 2013
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complexJohn R Prensner, Matthew K Iyer, Anirban Sahu, et al.
Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.
Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.
European Urology Oncology|June 11, 2024
Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate CancerPhilip Sutera, Yang Song, Amol C Shetty, et al.
Pageof 52

Showing results (501-510 of 519) with videos related to

Sort By:
Pageof 52
Genome Biology|March 28, 2008
A sequence-based survey of the complex structural organization of tumor genomesBenjamin J Raphael, Stanislav Volik, Peng Yu, et al.
Nature Medicine|April 3, 2023
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trialEugene Shenderov, Angelo M De Marzo, Tamara L Lotan, et al.
Neoplasia (New York, N.Y.)|October 26, 2012
Role of transcriptional corepressor CtBP1 in prostate cancer progressionRui Wang, Irfan A Asangani, Balabhadrapatruni V S K Chakravarthi, et al.
Human Molecular Genetics|May 13, 2004
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumorsPamela L Paris, Armann Andaya, Jane Fridlyand, et al.
Cancer Cell|May 18, 2011
Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancerJ Chad Brenner, Bushra Ateeq, Yong Li, et al.
JAMA Oncology|March 28, 2020
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical TrialRyan Phillips, William Yue Shi, Matthew Deek, et al.
Nature Genetics|October 1, 2013
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complexJohn R Prensner, Matthew K Iyer, Anirban Sahu, et al.
Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.
Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.
European Urology Oncology|June 11, 2024
Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate CancerPhilip Sutera, Yang Song, Amol C Shetty, et al.
Pageof 52